Mumbai (Maharashtra) [India]/ Dubai [UAE], February 13: In a landmark move that promises to transform digital healthcare, TruDoc Healthcare, the GCC's premier virtual primary care provider, is thrilled to announce its acquisition of Wellthy Therapeutics. Wellthy Therapeutics, Asia's leading
Surat (Gujarat) [India], November 25: In a groundbreaking development in the field of regenerative medicine, pioneering Stem Cell Therapy has provided astounding results, offering a glimpse into a future where ageing may no longer be an inevitability. Vasantbhai Gajera, Founder of Laxmi Grou
Gurugram (Haryana) [India], July 14: R1 RCM India (NASDAQ: RCM), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, recently announced that it has been recognized amongst Top 50 of India’s Best Companies
New Delhi [India], December 6 (ANI/PNN): Bestdoc - an end-to-end Patient Experience and Engagement solutions provider, deployed in over 250 Hospitals and Clinics across India and the Middle East has bagged the Innov8 Talks Startup competition. BD Concierge, the flagship product of BestDoc Te
Bangalore (Karnataka) [India], September 20 (ANI/PRNewswire): HealthEMAI, a mission-driven data platform company dedicated to improving care delivery, today announced its partnership with Marquee Dental Partners. Marquee, a leading dental service organization, provides dentists with both th
Hyderabad (Telangana) [India], July 15 (ANI/PNN): Youth is the building block of the future and power of any nation. India is one of the fastest growing economies looking to become a global economic power due to Gen X and millennials being geared toward Information Technology and Biotechnolo
London [UK], September 6 (ANI): A new study of patient experiences has shown that a next-generation brain implant currently in clinical use for treating refractory epilepsy -- to help prevent symptoms including seizures -- does not induce changes to patients' personalities or self-perception
Washington [US], December 9 (ANI): As rapid-release, cramp-inducing doses of chenodeoxycholic acid (CDC) have previously shown promise in treating constipation, but further development has been hampered by the abdominal pain associated with the sudden release of CDC--in preclinical studies.